Processa Pharma presents at World Orphan Drug Congress on Project Optimus for rare cancers

Processa Pharmaceuticals, Inc.

Dr. David Young participates in panel titled 'Clinical Development & Regulatory Panel Session: Patient focused drug development' at World Orphan Drug Congress on May 24, 2023.
Also presents Pitch and Partner presentation titled 'Applying FDA’s Project Optimus to the Next Generation of Chemotherapy Drugs Treating Rare Cancers' at 1:00 PM ET.
Presentation made available in Investors section of company website; detailed content not disclosed in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.